Cystadenocarcinoma, Serous
"Cystadenocarcinoma, Serous" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
A malignant cystic or semicystic neoplasm. It often occurs in the ovary and usually bilaterally. The external surface is usually covered with papillary excrescences. Microscopically, the papillary patterns are predominantly epithelial overgrowths with differentiated and undifferentiated papillary serous cystadenocarcinoma cells. Psammoma bodies may be present. The tumor generally adheres to surrounding structures and produces ascites. (From Hughes, Obstetric-Gynecologic Terminology, 1972, p185)
MeSH Number(s)
C04.557.470.200.025.480.240
C04.557.470.590.480.240
Concept/Terms
Cystadenocarcinoma, Serous- Cystadenocarcinoma, Serous
- Cystadenocarcinomas, Serous
- Serous Cystadenocarcinoma
- Serous Cystadenocarcinomas
Below are MeSH descriptors whose meaning is more general than "Cystadenocarcinoma, Serous".
Below are MeSH descriptors whose meaning is more specific than "Cystadenocarcinoma, Serous".
This graph shows the total number of publications written about "Cystadenocarcinoma, Serous" by people in Harvard Catalyst Profiles by year, and whether "Cystadenocarcinoma, Serous" was a major or minor topic of these publication.
To see the data from this visualization as text,
click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 1994 | 1 | 0 | 1 |
| 1996 | 0 | 1 | 1 |
| 1997 | 0 | 1 | 1 |
| 1998 | 0 | 1 | 1 |
| 2000 | 0 | 1 | 1 |
| 2001 | 1 | 0 | 1 |
| 2002 | 0 | 1 | 1 |
| 2003 | 1 | 3 | 4 |
| 2004 | 3 | 0 | 3 |
| 2005 | 1 | 3 | 4 |
| 2006 | 2 | 1 | 3 |
| 2007 | 6 | 4 | 10 |
| 2008 | 10 | 1 | 11 |
| 2009 | 9 | 0 | 9 |
| 2010 | 10 | 3 | 13 |
| 2011 | 7 | 5 | 12 |
| 2012 | 11 | 1 | 12 |
| 2013 | 13 | 4 | 17 |
| 2014 | 10 | 1 | 11 |
| 2015 | 11 | 2 | 13 |
| 2016 | 8 | 4 | 12 |
| 2017 | 9 | 3 | 12 |
| 2018 | 10 | 0 | 10 |
| 2019 | 9 | 3 | 12 |
| 2020 | 13 | 3 | 16 |
| 2021 | 10 | 0 | 10 |
| 2022 | 10 | 0 | 10 |
Below are the most recent publications written about "Cystadenocarcinoma, Serous" by people in Profiles.
-
CCNE1 and survival of patients with tubo-ovarian high-grade serous carcinoma: An Ovarian Tumor Tissue Analysis consortium study. Cancer. 2023 Mar 01; 129(5):697-713.
-
L1CAM is required for early dissemination of fallopian tube carcinoma precursors to the ovary. Commun Biol. 2022 12 12; 5(1):1362.
-
Clinical commentary extra-uterine high-grade serous carcinoma: Two pathways, two preventions? Gynecol Oncol. 2023 02; 169:1-3.
-
NCCN Guidelines® Insights: Ovarian Cancer, Version 3.2022. J Natl Compr Canc Netw. 2022 09; 20(9):972-980.
-
Metastatic Neoplasms Involving the Stomach. Am J Clin Pathol. 2022 06 07; 157(6):863-873.
-
BAP1 and Claudin-4, But Not MTAP, Reliably Distinguish Borderline and Low-grade Serous Ovarian Tumors From Peritoneal Mesothelioma. Int J Gynecol Pathol. 2023 Mar 01; 42(2):159-166.
-
Genomic catastrophe, the peritoneal cavity and ovarian cancer prevention. J Pathol. 2022 07; 257(3):255-261.
-
Multi-scale Pan-cancer Integrative Analyses Identify the STAT3-VSIR Axis as a Key Immunosuppressive Mechanism in Head and Neck Cancer. Clin Cancer Res. 2022 Mar 01; 28(5):984-992.
-
Single-cell tumor-immune microenvironment of BRCA1/2 mutated high-grade serous ovarian cancer. Nat Commun. 2022 02 11; 13(1):835.
-
Clinicopathologic Features of Gynecologic Malignancies Presenting Clinically as Colonic Malignancies. Am J Clin Pathol. 2022 Jan 06; 157(1):82-89.